- Continue Shopping
- Your Cart is Empty
HITLAB Digital Health Summit 2023 - Hexoskin Video
Our CEO Pierre-Alexandre Fournier presented some of Hexoskin's efforts to solve the evidence gap for healthcare and clinical trials at Columbia University last month, and HITLAB recently made the 15 minutes video available online below.
Clinical evidence is what makes medical discoveries possible: that's how we measure safety and efficacy, and that's how we measure efficiency gains in healthcare delivery. When we lower the cost of evidence, we make care more accessible and affordable. This is an important part of our mission at Hexoskin.
In the video you'll see a few examples of our work at Hexoskin, from clinical research to AI development to human spaceflight.
The Hexoskin and Astroskin platform has been used to collect health data for over 200 scientific publications. White papers about wearable sensors applications for health monitoring of are available upon request.
Hexoskin at HITLAB Digital Health Summit 2023 in New York
Hexoskin's co-founder and CEO, Pierre-Alexandre Fournier, has been invited to speak at the prestigious HITLAB Innovator Summit 2023, hosted at Columbia University in New York City this June 27-29.
In the past 10 years we have seen enormous progress in the use of digital technologies in healthcare to support a wide range of activities: remote care, remote diagnostics, access to medical data, artificial intelligence, virtual clinical trials, genetic analysis, digital biomarker development, molecule discovery, etc. Despite all this progress, patients, physicians, scientists and researchers agree we have barely started to use digital tools to address our growing need for efficient healthcare, therapies and population health management.
The event includes speakers from Merck, Takeda, Pfizer, Syneos, Medidata, CVS, Novo Nordisk, Microsoft, Mount Sinai Health System, Brigham and Women’s Hospital, and many other organizations working to improve human health and access to care.
Please reach out to us if you'd like to arrange a meeting during the event: contact@hexoskin.com
Tickets are still available, and you can get 20% off with the special code SUMMITPAF23.
About Hexoskin
Founded in 2006 in Montreal, Hexoskin is a leader in wearable sensors, software, data science & AI services. The company provides solutions and services to researchers & professionals in pharmaceuticals, academics, healthcare, defense, first responders, space, and aerospace organizations.
Hexoskin's Co-Founder and CEO Pierre-Alexandre Fournier on The Bleeding Edge of Digital Health Podcast
In this episode of the Bleeding Edge of Digital Health, host Mike Moore speaks with entrepreneur, scientist, and co-founder of Hexoskin, Pierre-Alexander Fournier.
Mike and Pierre talk about how his latest tech garment is being utilized in health care today, how it is benefiting not just the patient but the physician as well, and more importantly, the future products and garments in Hexoskin’s pipeline that will pave the way for further innovation and change the way we take care of our health, and the health of the ones we care about. Be sure to listen to the entire session.
Notable Quotes
“So, we're working on different garments. We do have another product that has more sensors called the Astroskin that is being used in research, and that's the product that is being used in the space station right now for different research projects in microgravity. The Astroskin is the model Chris Hemsworth is wearing in Limitless.”
“Research groups we're working with have built the largest database of vital signs for many specific health conditions. So, there are a lot of things that will come out of it. And as I said earlier, we're not just building a product for single use. Eventually, we're going to add blocks to that platform so that it can be used for several types of disease, and it's going to become a great bundle for people with comorbidities.”
Podcast links:
CGI and Hexoskin to Work Together on Connected Medical Clinic Project
The Canadian Space Agency (CSA) has awarded contracts to five teams to build prototypes of the Connected Care Medical Module (C²M²), a container-based concept for mobile medical clinics that can be rapidly deployed in remote, northern, or indigenous communities across Canada, in regions affected by natural disasters, and in future lunar and deep space missions.
Hexoskin (Carré Technologies Inc.) is proud to be part of the HARMONY team, led by CGI, one of the largest IT firms in the world, along with OKAKI Health Intelligence, PrecisionOS Technology, 12Volt: Games Studio, and Dr. Carolyn McGregor of the University of Ontario Institute of Technology.
Hexoskin will contribute Astroskin devices and AI-based medical software to the project. A first demonstration is planned for June 2023.
About the Connected Care Medical Modules
Health Beyond's vision is to enable agile, rapid prototyping and iterative operation of C²M²s on Earth, with the ultimate objective of operation in space. A C²M² is a scalable integrated system of state-of-the-art medical technologies and methodologies contained in a deployable unit. A shipping container will first be used for research and development purposes and for easy deployment across Canada via the existing intermodal freight transportation network. When preparing for space application and deployment in remote communities with collaborators, the medical module can be scaled down and adapted as needed.
One of the novel features of the C²M² is its core computer-based system that facilitates the incorporation, interconnection (i.e., flow of information), and usage of the latest medical technologies. This plug and play architecture will enable multiple configurations based on the end users' needs. These technologies increase the user's capacity to independently detect, diagnose, treat, and/or monitor health conditions on site. This improves the timeliness, quality, and continuity of care; refines clinical decision-making; and reduces the occurrence of risky and expensive medical transportation of patients from remote regions to urban hospital facilities.
(photo: Canadian Space Agency)
Hexoskin at Biosensors for Medical Wearables in Boston: Overcoming Challenges in Long-Term Medical Monitoring
Hexoskin's co-founder and CEO Pierre-Alexandre Fournier has been invited to talk about long-term vital signs monitoring at the Biosensors for Medical Wearables Conference in Boston on October 25th.
Vital signs sensors traditionally used for cardiac and respiratory monitoring involve adhesives or tape to keep the sensors in place on the skin. Experience has shown there's a tradeoff between monitoring duration (1 to 14 days), and adhesive agressiveness, which can lead to skin rashes or wounds.
There's now a safer and more convenient way for patients to record long-term vital signs data needed for diagnosis or to guide care or rehabilitation: smart textiles. Hexoskin users have successfully demonstrated the advantages of using a form factor that patients like. Researchers have documented it in over 200 scientific papers.
In his talk, Fournier will describe medical applications of smart textile sensors for patients with cardiac and respiratory diseases, as well as opportunities in research in mental health and rare diseases. He will also share unique insights into Hexoskin's experience in space medicine research aboard the International Space Station.
Please reach out for more information: contact@hexoskin.com
Stanford Wearable Electronic Initiative - Hexoskin Seminar
Hexoskin's CEO Pierre-Alexandre Fournier was invited to speak at a seminar co-hosted by Stanford eWEAR and Stanford Medicine's Precision Health and Integrated Diagnostics Center (PHIND) held online on December 1st. The seminar covered the capabilities of wearable technologies and Hexoskin to support the early detection of diseases such as the COVID-19 onset.
With over 100 Scientific Publications and validations, Hexoskin has the only clinically validated biometric garment which provides continuous monitoring of numerous and unique physiological parameters. It is an enabling technology for telehealth use cases, such as remote patient monitoring, at-home cardiovascular and pulmonary rehabilitation, and post-acute care.
Along with its smart clothing, Hexoskin offers a unique set of high-resolution biometric data that can continuously monitor activity, sleep, cardiac and respiratory data. Projects in fields such as cardiology, respiratory, behavioral and physiological psychology, biofeedback research, sleep research, and health will be presented during the seminar.
The Hexoskin Connected Health Platform provides researchers with accessible solutions such as the Hexoskin Dashboards, Open API, and Apps to manage, visualize, annotate, analyze, and export raw & processed health data. Data extraction tools allow access to the raw data with time series for machine learning and artificial intelligence projects, making Hexoskin and excellent solution to collect high-resolution data quickly to deliver projects and results. Watch it online today!
Webinar on Continuous & Remote Respiratory Monitoring With Hexoskin
We thank all our attendees and Guests Speakers who participated in our Live Webinar on Continuous & Remote Respiratory Monitoring with Hexoskin - In the Era of Chronic Illness, Pandemics & Limited Health Resources, on August 25th, 2020! If you were not able to attend live, and wish to watch it, you can now access the Webinar's recording:
Over 250 guests registered for this panel with our guest speakers Dr. Dennis Jensen (McGill University), and Denise Mannée (Radboud University Medical Center). In this session we discussed the benefits and considerations of digital technologies for Healthcare Providers, Researchers and Patients, and provide real-world evidence of Hexoskin's remote respiratory monitoring capabilities.
If you couldn't attend, and wish to watch it, you can now request access to the Webinar's recording. Thank you for your interest and feel free to reach out if you have any questions.
Hexoskin and Halo Health to solve key challenges of clinical trials.
Hexoskin and Halo Health are announcing today a collaboration to solve key challenges in running clinical trials. Combining Hexoskin and Halo Health's technology will offer greater operational efficiency for virtual clinical trials and home monitoring, and offer tools to increase patient engagement.
These new tools will reduce the cost of collecting vital signs data for clinical trials, and will allow patients to participate in medical research from the comfort of their home.
Hexoskin smart garments and its Connected Health Platform are compatible with Halo Health solutions. The two companies will mutually promote their offering to pharmaceutical sponsors to support clinical development.
Halo Health is enabling patient-centric trials to reduce patient and site burden. Its Smart Clinical Trials solution is a digital health platform that provides Remote Patient Monitoring, Patient Engagement, and Workflow Automation. The solution includes an integrated ecosystem of clinical grade sensors and wearables to enable hybrid & virtual trials for various therapeutic areas including cardiology, respiratory and endocrinology.
Pierre-Alexandre Fournier - Chief Executive Officer at Hexoskin: “Medicine's progress depends on being able to better observe patients' outcomes. Anything we can do to lower the cost of data helps accelerate clinical development. This is something that Pharma and Biotech companies need to innovate, but most importantly this is something that we need to do to improve treatments for patients and find new cures for diseases that affect millions of people and their families.” says Pierre-Alexandre Fournier, Chief Executive Officer at Hexoskin. “Combining Halo Health's software with Hexoskin sensors and algorithms reduces the cost of collecting data in clinical trials, with greater flexibility & patient centricity.”
Hexoskin is a pioneer and leader in non-invasive vital signs sensors and remote patient monitoring solutions. Hexoskin Smart Clothing for Men, Women, and Children are clinically validated and its Connected Health Platform is used for health research in cardiology, pulmonology, psychiatry, rare diseases and many other health conditions.
We’re attending #DPHARM2019 in #Boston, at HaloHealth's Kiosk on September 17 & 18, 2019! Visit Booth 30 to learn about our joint innovative solutions to solve the key challenges of Clinical-trials!
Contact Hexoskin to learn more.
Advancing space medicine knowledge aboard the ISS. Another space mission for Astroskin / Bio-Monitor!
Earlier this month, European Space Agency astronaut Luca Parmitano conducted validation tests on-orbit and wore the Astroskin garment and headband connected to the data unit for his first 72-hour monitoring experience.
Luca Parmitano also conducted maintenance operations for the Astroskin / Bio-Monitor that was deployed on the ISS orbiting lab, last December by Canadian Astronaut David Saint-Jacques.
Although the ISS is equipped with health and life sciences research tools, the existing instrumentation for continuous and simultaneous recording of several physiological parameters was lacking. To address this issue, the Canadian Space Agency's Bio-Monitor Commissioning activity uses the Astroskin / Bio-Monitor system; a complete vital signs monitoring platform coupled with a wearable garment capable of monitoring relevant physiological parameters in a non-invasive and non-interfering way during a normal day in space.
The physiological parameters which can be monitored consist of blood pressure, peripheral blood oxygen saturation, 3-lead ECG, respiration, skin temperature, and activity, will help push further our understanding of Vascular aging and Human Physiology in space.
Venturing into the environment of space, microgravity can have negative effects on the human body. When astronauts return to Earth, their carotid arteries, which carry blood to the head and neck, appear to have aged 20 to 30 years. Artery walls become stiffer and thicker in space, the same as when people grow older on Earth.
“You can take extremely healthy, fit astronauts and put them in an environment that restricts their ability to do daily exercise, and they run the risk of developing insulin resistance that on Earth could lead to Type II diabetes,” said principal investigator Richard L. Hughson of Schlegel-University of Waterloo in Ontario
Now operational the Astroskin Bio-Monitor system is available for the next five years to conduct Health research in Space for all participating countries to the International Space Station.
Sometimes you wear the experiment: the Bio-Monitor smart shirt system measures vital signs like temperature, heart rate, respiration and movement, and transmits the data to a tablet application. #MissionBeyond @csa_asc pic.twitter.com/2h6lmRUyHH
— Luca Parmitano (@astro_luca) 19 août 2019
Source:
NASA. 2019. ISS Daily Summary Report - 8/14/2019
NASA. 2019. ISS Daily Summary Report - 8/13/2019
About Hexoskin
Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. The Astroskin demonstrates once again Hexoskin’s leadership in providing the industry leading sensors, software, and AI to push further our understanding of human physiology on earth and in space.
Hexoskin Unveils Smart Tools for Connected Health & Patient Remote Monitoring
In 2013, Hexoskin launched a unique solution that revolutionized how we monitor cardiac, respiratory, activity, and sleep data with sensors embedded in a comfortable and machine washable smart garment.
Hexoskin was the first smart clothing compatible with the iPhone. We also opened our API to allow developers and researchers to leverage the value provided by our solutions.
Today, the Hexoskin Connected Health Platform is an end-to-end solution that offers leading-edge sensors, software, and data science tools. It is used by researchers, public and private organizations, athletes, and users who value precise, accessible, and useful health data.
The Hexoskin Connected Health Platform is currently used for Machine Learning and Artificial Intelligence research and projects that will change how patients receive care. Here is an overview of the Hexoskin Connected Health Platform.
The Hexoskin Connected Platform is a powerful, yet flexible option that can fit any project sizes. Try it today ! Visit our Health Research Page to learn more about the research and validation conducted with Hexoskin. You can always contact us if you have any questions or need advises on how to leverage the Hexoskin Connected Health Platform for your research or project.
About Hexoskin
Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.
